Alto Neuroscience Ownership | Who Owns Alto Neuroscience?
Alto Neuroscience Ownership Summary
Alto Neuroscience is owned by 63.89% institutional investors, 7.48% insiders, and 28.63% retail investors. Alpha wave global, lp is the largest institutional shareholder, holding 13.70% of ANRO shares.
ANRO Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Alto Neuroscience | 63.89% | 7.48% | 28.63% |
| Sector | Healthcare Stocks | 488.17% | 11.08% | -399.26% |
| Industry | Biotech Stocks | 306.59% | 11.10% | -217.69% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Alpha wave global, lp | 3.71M | 13.70% | $8.16M |
| Armistice capital | 1.62M | 6.00% | $3.57M |
| Point72 asset management | 1.33M | 4.91% | $2.93M |
| Vestal point capital, lp | 950.00K | 3.51% | $2.09M |
| Marshall wace, llp | 937.41K | 3.46% | $2.06M |
| Blackrock funding, inc. /de | 561.85K | 2.08% | $1.24M |
| Alkeon capital management | 477.10K | 1.76% | $1.05M |
| Integral health asset management | 400.00K | 1.48% | $880.00K |
| Awm investment company | 280.48K | 1.04% | $617.06K |
| Orbimed advisors | 250.00K | 0.92% | $550.00K |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Alpha wave global, lp | 3.71M | 0.88% | $8.16M |
| Vestal point capital, lp | 950.00K | 0.11% | $2.09M |
| Almitas capital | 195.15K | 0.11% | $429.32K |
| Integral health asset management | 400.00K | 0.08% | $880.00K |
| Awm investment company | 280.48K | 0.07% | $617.06K |
| Armistice capital | 1.62M | 0.06% | $3.57M |
| Ikarian capital | 110.00K | 0.05% | $242.00K |
| Orbimed advisors | 250.00K | 0.01% | $550.00K |
| Wetherby asset management | 84.16K | 0.01% | $185.16K |
| Point72 asset management | 1.33M | 0.01% | $2.93M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Point72 asset management | 1.33M | 0.01% | 89.70K |
| Marshall wace, llp | 937.41K | 0.00% | 84.42K |
| Wetherby asset management | 84.16K | 0.01% | 84.16K |
| Y-intercept (hong kong) | 38.60K | 0.00% | 38.60K |
| Vestal point capital, lp | 950.00K | 0.11% | 35.00K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Blackrock funding, inc. /de | 561.85K | - | -897.33K |
| Awm investment company | 280.48K | 0.07% | -621.50K |
| Woodline partners lp | - | - | -359.87K |
| Td asset management | - | - | -110.79K |
| Wellington management group llp | - | - | -77.15K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Wetherby asset management | 84.16K | 0.01% | 84.16K | $185.16K |
| Y-intercept (hong kong) | 38.60K | 0.00% | 38.60K | $84.91K |
| Acadian asset management | 26.48K | 0.00% | 26.48K | $57.00K |
| Drw securities | 14.08K | 0.00% | 14.08K | $30.98K |
| Fortitude family office | 292.00 | 0.00% | 292.00 | $642.00 |
Sold Out
| Holder | Change |
|---|---|
| Sterling capital management | -161.00 |
| Russell investments group | -177.00 |
| Nelson, van denburg & campbell wealth management group | -249.00 |
| Physician wealth advisors | -377.00 |
| Simplex trading | -584.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2025 | 79 | -7.06% | 17,296,404 | -16.08% | 63 | 1.10% | 42 | 7.69% | 21 | -16.00% |
| Mar 31, 2025 | 86 | 7.50% | 20,845,493 | -6.06% | 77 | 1.14% | 39 | -23.53% | 26 | 100.00% |
| Dec 31, 2024 | 81 | -5.81% | 22,530,140 | -1.78% | 83 | 1.15% | 52 | -21.21% | 13 | 44.44% |
| Sep 30, 2024 | 86 | 48.28% | 22,939,574 | 23.33% | 85 | 1.79% | 66 | 69.23% | 9 | -10.00% |
| Jun 30, 2024 | 58 | 11.54% | 18,600,674 | 16.67% | 69 | 1.96% | 39 | -25.00% | 10 | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Jul 10, 2024 | Savitz Adam | CHIEF MEDICAL OFFICER | Buy | $38.75K |
| Jul 09, 2024 | Savitz Adam | CHIEF MEDICAL OFFICER | Buy | $18.25K |
| Jul 09, 2024 | Savitz Adam | CHIEF MEDICAL OFFICER | Buy | $133.83K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q3 | - | - |
| 2025 Q2 | - | - |
| 2025 Q1 | - | - |
| 2024 Q3 | 3 | - |
ANRO Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools